Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Psoriasis and Psoriatic Disorders Clinical Trials

A listing of Psoriasis and Psoriatic Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (64) clinical trials

This study will be conducted to evaluate the therapeutic bioequivalence of a TEST formulation of calcipotriene hydrate and betamethasone dipropionate topical suspension 0.005%/0.064% to the RLD.

Phase

ActivMed Practices and Research is looking for volunteers to participate in a nationwide study on chronic plaque psoriasis. If you are 18 or older, and have been diagnosed with chronic plaque psoriasis for at least 6 months, you may qualify for this study.

Phase

Volunteers with neutrophilic skin disease are needed to participate in a research study to assess the safety, tolerability, and activity of an investigational drug that is being developed as a potential treatment for plaque psoriasis, palmoplantar pustulosis, or hidradenitis suppurativa. Eligible participants will be men and women diagnosed with one ...

Phase

We are conducting a research study evaluating the safety and effectiveness of an investigational shampoo for scalp psoriasis. Qualified participants will receive study related exams and study medication at no charge. Please contact us today!

Phase N/A

We are conducting a research study evaluating the safety and effectiveness of an investigational medication for psoriasis. Qualified participants will receive study related exams and study medication at no charge. Please contact us today!

Phase N/A

A 52-week, multicenter, randomized, double-blind study of secukinumab (300mg) to demonstrate efficacy as assessed by psoriasis area and severity index and investigator's global assessment after 12 weeks of treatment, compared to ustekinumab, and to assess long-term safety, tolerability, and efficacy in subjects with moderate to severe plaque psoriasis.

Phase

We are studying an injectable medication, secukinumab, in the treatment of moderate to severe plaque psoriasis. Patients will undergo 3 FDG-PET/CT scans during the study to assess inflammation of the large vessels in the body and the effects of secukinumab on this inflammation. The trial lasts for 52 weeks. Initially ...

Phase N/A